188 related articles for article (PubMed ID: 11401941)
1. Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice.
Caligiuri G; Rottenberg M; Nicoletti A; Wigzell H; Hansson GK
Circulation; 2001 Jun; 103(23):2834-8. PubMed ID: 11401941
[TBL] [Abstract][Full Text] [Related]
2. Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.
Aalto-Setälä K; Laitinen K; Erkkilä L; Leinonen M; Jauhiainen M; Ehnholm C; Tamminen M; Puolakkainen M; Penttilä I; Saikku P
Arterioscler Thromb Vasc Biol; 2001 Apr; 21(4):578-84. PubMed ID: 11304476
[TBL] [Abstract][Full Text] [Related]
3. Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae.
Rothstein NM; Quinn TC; Madico G; Gaydos CA; Lowenstein CJ
J Infect Dis; 2001 Jan; 183(2):232-238. PubMed ID: 11120929
[TBL] [Abstract][Full Text] [Related]
4. Mouse models of Chlamydia pneumoniae infection and atherosclerosis.
Campbell LA; Kuo Cc
Am Heart J; 1999 Nov; 138(5 Pt 2):S516-8. PubMed ID: 10539863
[No Abstract] [Full Text] [Related]
5. Apolipoprotein E-deficient mice develop an anti-Chlamydophila pneumoniae T helper 2 response and resist vascular infection.
Nazzal D; Therville N; Yacoub-Youssef H; Garcia V; Thomsen M; Levade T; Segui B; Benoist H
J Infect Dis; 2010 Sep; 202(5):782-90. PubMed ID: 20632890
[TBL] [Abstract][Full Text] [Related]
6. Murine models of Chlamydia pneumoniae infection and atherosclerosis.
Moazed TC; Kuo C; Grayston JT; Campbell LA
J Infect Dis; 1997 Apr; 175(4):883-90. PubMed ID: 9086145
[TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis in apoE knockout mice infected with multiple pathogens.
Burnett MS; Gaydos CA; Madico GE; Glad SM; Paigen B; Quinn TC; Epstein SE
J Infect Dis; 2001 Jan; 183(2):226-231. PubMed ID: 11120928
[TBL] [Abstract][Full Text] [Related]
8. A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice.
Sorrentino R; Yilmaz A; Schubert K; Crother TR; Pinto A; Shimada K; Arditi M; Chen S
Cell Immunol; 2015 Mar; 294(1):25-32. PubMed ID: 25666507
[TBL] [Abstract][Full Text] [Related]
9. Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
Moazed TC; Campbell LA; Rosenfeld ME; Grayston JT; Kuo CC
J Infect Dis; 1999 Jul; 180(1):238-41. PubMed ID: 10353889
[TBL] [Abstract][Full Text] [Related]
10. Mouse models of C. pneumoniae infection and atherosclerosis.
Campbell LA; Blessing E; Rosenfeld M; Lin Tm; Kuo C
J Infect Dis; 2000 Jun; 181 Suppl 3():S508-13. PubMed ID: 10839749
[TBL] [Abstract][Full Text] [Related]
11. Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis.
Chen S; Shimada K; Crother TR; Erbay E; Shah PK; Arditi M
J Am Coll Cardiol; 2018 Apr; 71(14):1553-1570. PubMed ID: 29622163
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice.
Zafiratos MT; Manam S; Henderson KK; Ramsey KH; Murthy AK
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26220574
[TBL] [Abstract][Full Text] [Related]
13. Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.
Törmäkangas L; Erkkilä L; Korhonen T; Tiirola T; Bloigu A; Saikku P; Leinonen M
Infect Immun; 2005 Oct; 73(10):6458-66. PubMed ID: 16177317
[TBL] [Abstract][Full Text] [Related]
14. Effect of Chlamydia trachomatis infection on atherosclerosis in apolipoprotein E-deficient mice.
Blessing E; Nagano S; Campbell LA; Rosenfeld ME; Kuo CC
Infect Immun; 2000 Dec; 68(12):7195-7. PubMed ID: 11083855
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between serum immunoreactivity and Chlamydia pneumoniae detection in the human aortic wall.
Porqueddu M; Spirito R; Parolari A; Zanobini M; Pompilio G; Polvani G; Alamanni F; Stangalini D; Tremoli E; Biglioli P
Circulation; 2002 Nov; 106(21):2647-8. PubMed ID: 12438287
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor receptor superfamily members 1a and 1b contribute to exacerbation of atherosclerosis by Chlamydia pneumoniae in mice.
Zafiratos MT; Cottrell JT; Manam S; Henderson KK; Ramsey KH; Murthy AK
Microbes Infect; 2019 Mar; 21(2):104-108. PubMed ID: 30292879
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of XIAP leads to sensitization for Chlamydophila pneumoniae pulmonary infection and dysregulation of innate immune response in mice.
Prakash H; Albrecht M; Becker D; Kuhlmann T; Rudel T
J Biol Chem; 2010 Jun; 285(26):20291-302. PubMed ID: 20427267
[TBL] [Abstract][Full Text] [Related]
18. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model.
Li L; Messas E; Batista EL; Levine RA; Amar S
Circulation; 2002 Feb; 105(7):861-7. PubMed ID: 11854128
[TBL] [Abstract][Full Text] [Related]
19. A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae.
Blessing E; Campbell LA; Rosenfeld ME; Chesebro B; Kuo CC
J Antimicrob Chemother; 2005 Jun; 55(6):1037-40. PubMed ID: 15845780
[TBL] [Abstract][Full Text] [Related]
20. Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.
Damy SB; Higuchi ML; Timenetsky J; Reis MM; Palomino SP; Ikegami RN; Santos FP; Osaka JT; Figueiredo LP
BMC Microbiol; 2009 Sep; 9():194. PubMed ID: 19744321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
